Free Trial

Truist Financial Boosts Procter & Gamble (NYSE:PG) Price Target to $185.00

Procter & Gamble logo with Consumer Staples background

Procter & Gamble (NYSE:PG - Get Free Report) had its target price raised by research analysts at Truist Financial from $180.00 to $185.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Truist Financial's price objective would indicate a potential upside of 12.99% from the company's current price.

Other equities research analysts have also issued reports about the company. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday, March 27th. Wells Fargo & Company lifted their price objective on shares of Procter & Gamble from $176.00 to $180.00 and gave the stock an "overweight" rating in a research note on Thursday, January 23rd. UBS Group reissued a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Stifel Nicolaus lifted their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Finally, Piper Sandler dropped their target price on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a research report on Monday, February 24th. Seven equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus target price of $182.00.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Price Performance

NYSE:PG traded down $8.66 during trading hours on Thursday, reaching $163.73. The stock had a trading volume of 13,446,957 shares, compared to its average volume of 6,942,870. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The stock has a market capitalization of $383.92 billion, a PE ratio of 26.07, a PEG ratio of 3.76 and a beta of 0.43. Procter & Gamble has a 52 week low of $153.52 and a 52 week high of $180.43. The company has a 50 day moving average price of $169.17 and a two-hundred day moving average price of $169.15.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The business had revenue of $21.88 billion during the quarter, compared to analyst estimates of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. Procter & Gamble's quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.84 earnings per share. As a group, sell-side analysts anticipate that Procter & Gamble will post 6.91 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Gary A. Coombe sold 35,000 shares of the business's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the completion of the transaction, the chief executive officer now owns 22,051 shares in the company, valued at $3,829,817.68. The trade was a 61.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction that occurred on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the sale, the insider now owns 172,814 shares of the company's stock, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 143,450 shares of company stock worth $23,988,008. 0.18% of the stock is currently owned by company insiders.

Institutional Trading of Procter & Gamble

Institutional investors have recently made changes to their positions in the business. NewSquare Capital LLC grew its stake in shares of Procter & Gamble by 933.3% during the fourth quarter. NewSquare Capital LLC now owns 155 shares of the company's stock worth $26,000 after acquiring an additional 140 shares during the last quarter. Navigoe LLC acquired a new stake in Procter & Gamble in the 4th quarter worth approximately $31,000. Capital A Wealth Management LLC purchased a new stake in Procter & Gamble during the 4th quarter worth approximately $31,000. Hoey Investments Inc. increased its stake in Procter & Gamble by 321.7% during the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after purchasing an additional 148 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA acquired a new stake in shares of Procter & Gamble during the fourth quarter worth $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines